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Abstract 
In the past few decades, attention and research in the field of stem cell are progressing very rapidly. Hospitals in 
Indonesia have been using stem cells as an alternative to cure some illnesses like diabetes, heart disease, fractures 
and joints, dental implants, etc. Currently, adult stem cells can be obtained not only from the spinal cord and peripheral 
vessels, but also from fat tissues of the human body, where it can be isolated as adherent stem cells (mesenchymal 
stem cells). Consideration of fat tissue as the source of mesenchymal stem cells (MSCs) for autologous tissue 
engineering is because they are readily available in abundant quantities through minimal invasive procedures, as 
well as easily cultured and propagated. It is possible to proliferate and differentiate into the desired direction of the 
network. Stem cell growth requires conditions to grow such as requiring optimum growing conditions such as an 
environmental temperature of 37°C and a concentration of 5% CO2. Maintenance of MSCs also requires a subculture 
process, i.e. the process of moving MSCs from a full culture medium to new media; continuous subculture process can 
cause changes in MSCs. The viability of stem cells may be disrupted by micro-conditions in wounds such as hypoxia, 
oxidative stress, and inflammation. Therefore, the purpose of this research was to investigate whether alginate-based 
encapsulation can increase and maintenance stem cell growth at different temperature by using some concentration 
of alginate and CaCl2 as the formula. Results shown that alginat with low concentration and CaCl2 100mM is suitable 
for MSCs growth (as in MTT result shown) at 25°C temperature. This can be due to the MSCs encapsulated can adapt 
and grow within the alginate microcapsule with low concentration. In addition, the media may also easier to get into 
the microcapsule alginate. 
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Introduction 
Mesenchymal stem cells (MSCs) are a prospective object for the 
use in cell therapy and intensely studied by many research groups. 
MSCs are characterized primarily by expression of surface markers 
and differentiation potential. MSCs express a series of specific markers 
(CD44, CD90, CD105, CD13, etc.) and should differentiate into cells of 
mesodermal origin such as adipocytes, osteoblasts and chondroicytes. 
Due to the easy accessible anatomical location and the abundant 
existence of subcutaneous adipose tissue, ADSC hold the advantage of a 
simple and above all less invasive harvesting technique. Consideration of 
fat tissue as the source of mesenchymal stem cells (MSCs) for autologous 
tissue engineering is because they are readily available in abundant 
quantities through minimal invasive procedures, as well as easily 
cultured and propagated. It is possible to proliferate and differentiate 
into the desired direction of the network. Stem cell growth requires 
conditions to grow such as requiring optimum growing conditions 
such as an environmental temperature of 37°C and a concentration    
of 5% CO
2
. Maintenance of MSCs also requires a subculture process, 
i.e. the process of moving MSCs from a full culture medium to new 
media; continuous subculture process can cause changes in MSCs. The 
viability of stem cells may be disrupted by micro-conditions in wounds 
such as hypoxia, oxidative stress, and inflammation. 
Alginate is an anionic polymer compound which can be obtained 
from brown algae and Pseudomonas and Azotobacter microbes. 
Alginate includes a group of non-branched and non-recurrent 
exopolisakarida composed of two monomers namely β-D-mannuronic 
acid and α-L-guluronic acid. Alginate will interact with divalent cations, 
such as Ca2+, and form a 3D structure. The ability of alginate to form 3D 
structure and its low toxicity characteristics and high biocompatibility 
make alginate widely used for encapsulation process. 
Cell encapsulation is a method of cell capture in a polymeric 
semipermeable membrane, generally biocompatible encapsulation 
materials such as chitosan, hyaluronic acid, and alginate. Encapsulation 
is generally done to protect the cell. Encryption of embryonic stem cells 
with alginate is reported to maintain viability of stem cells for 110 days 
without undergoing differentiation and without requiring subculture 
maintenance [1]. Encapsulation of MSCs with alginate-CaCl
2 
is known 
to maintain viability in hypothermic conditions (<37°C) and without 
specific gas concentrations [2]. Encapsulation can also protect stem 
cells from frictional forces, microenvironment, and immune responses 
[3]. The method of cell encapsulation involves 2 main stages: dispersion 
of the solution containing the cell to be small and followed by gelation 
or membrane formation on the  surface  of  the  dispersed  solution, 
for example extrusion method of droplets. Alginate solution will be 
extruded through nozzle or needle so as to produce droplets of a certain 
size. The droplet size setting can be done by adjusting the extrusion 
speed and the size of the nozzle [4-9]. Therefore, the purpose of this 
research was to investigate whether alginate-based encapsulation can 
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increase and maintenance stem cell viability at diferent temperature by 
using some concentration of alginate and CaCl
2 
as formula. 
Material and Methods 
Mesenchymal Stem Cell Culture (MSCs) 
MSCs were cultured on α-MEM media given the addition of 
Platelet Rich Plasma (PRP), Penicillin / Streptomycin, and Heparin. 
Media replacement grows every 3 days. MSCs subculture is growth well 
when the MSCs are confluent ± 80%. 
MSCs encapsulation optimization 
Optimization of CaCl
2 
concentrations: Alginate solution (Sigma 
Aldrich, medium viscosity) was prepared at concentrations of 1.25% (w 
/ v). The 1 × 106 mesenchymal stem cells are mixed in 1 ml of alginate 
solution. The solution was then dropped in the form of droplets by 
extrusion method using a 31 G syringe at 200 mM CaCl
2 
solution 
Analysis of stem cell encapsulation 
De-capsulation of alginate-based microcapsules: Microcapsules 
were observed morphologically through a microscope every  day  
until day 28. On the 1st, 7th, 14th, 21st and 28th days, a viability test and 
stability of mesenchymal stem cells in microcapsules were performed. 
The microcapsules were decapitated using 500 mM EDTA solution/10 
mM HEPES in 500 mL PBS. Decapsulation incubate in 15 minutes in a 
waterbath shaker with a temperature of 37oC. The solution mixture was 
then centrifuged for 5 minutes at a rate of 1200 rpm and obtained a cell 
pellet which was then diluted with 2 ml growing medium. 
MTT (3- (4,5-Dimethylthiazol-2-yl) -2,5-Diphenyltetrazolium 
Bromide) assay: The viability of mesenchymal stem cells during the 
process of encapsulation and incubation of cells can remain proliferate 
using MTT assay. Transfer of decapsulated cells into the wells is 100 μL. 
Added reagent of MTT (0.5 mg / mL) as much as 100μL then incubation 
in incubator 37oC, 5% CO
2 
for 4 hours. After that add 10% SDS into the 
well and incubated for 24 hours at room temperature. Absorbance was 
with contact time of + 30 min. The formed microcapsules were then 
washed using 0.9% NaCl 3 times and stored in culture medium. The 
concentration of CaCl
2 
to be used in the next step was selected based 
on the results of the MSCs encapsulated viability test on days 0, 1, 7, 
14, 21, 28. 
Alginate encapsulation optimization: Alginate solution was 
prepared at concentrations of 1% in Aqua Sterile. The 1 × 106 
mesenchyme stem cells are mixed in 1 ml of alginate solution. Alginate 
solution at various concentrations was then dropped in the form of 
droplets by extrusion method using 31 G syringe at CaCl
2 
solution with 
concentration based on CaCl
2 
concentration optimization result with 
contact time + 30 min. The formed microcapsules were then washed 
using 0.9% NaCl and stored in culture medium. These microcapsules 
are incubated at different temperatures at 4°C (refrigeratore) and 37°C 
(incubator) for 0-28 days. The optimum concentration of alginate is 
selected by testing the viability and stability of MSCs encapsulated. 
measured using an ELISA reader at a wavelength of 595 nm. 
Live dead assay (LDA): Live Dead Assay were analyze using 
Propidium Iodine (PI) as a marker of dead cells and Calcein Am as a 
living cell marker, with concentrations of PI = 10 μM and Calcein 2 μM. 
Stability analysis: The cell stability assay was used to see whether 
differentiation of mesenchymal stem cells during encapsulation was 
performed. Differentiation into adipocyte cells was tested using Oil 
red-O staining, whereas differentiation testing became chondrocytes 
and osteoblasts were each tested using alcian blue and alizarin red 
staining. 
Result and Discussion 
Alginate 2% with CaCl2 100mM (Figure 1 and 1a) 
MTT (3- (4,5-Dimethylthiazol-2-yl) -2,5-Diphenyltetrazolium 
Bromide) Assay: At 37°C temperature indicates that the growth of 
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Figure 1: Absorbance value based on MTT assay of Alginate 2% with CaCl
2 
100 mM at 37°C. 
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Figure 1a: Absorbance value based on MTT assay of Alginate 2% with CaCl
2 
100 mM at 25°C. 
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MSCs in alginate microcapsules begins to increase on the 7th day until 
the 21st day. While after the 21st day, the growth of MSCs began to look 
declining. This can be due to the need for time for the MSCs to adapt and 
grow within the alginate microcapsule. In addition, the media may also 
need time to get into the microcapsule alginate. While MSCs growth in 
37°C temperature can grow well due to conditions in temperature 37°C 
is the optimum temperature for stem cells to grow. At 25°C temperature 
indicates that the growth of MSCs in alginate microcapsules begins to 
increase on the 7th day. While after the 7th day, the growth of MSCs 
began to look declining continously. This can be due to the need for 
time for the MSCs to adapt and grow within the alginate microcapsule. 
Live dead assay (LDA): Viability of MSCs after alginate 
encapsulated MSCs for day-0, day-1, day-7, day-14, day-21, and day-28 
using Live-dead cell assay (Alginate 2% with CaCl
2 
100mM) (Table 1). 
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Table 1: Viability of MSCs after alginate encapsulated MSCs for day-0, day-1, day-7, day-14, day-21, and day-28  using Live-dead cell assay (Alginate 2% with CaCl
2  
100 mM). 
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Stability assay (Table 2): From the LDA analysis shows that 
MSCs is still alive from day-0 to day-28 in the alginate microcapsule 
but seen the amount of MSCs decreased from day-0 to day-28. And 
from stability analysis shows that there is no adipose, chondrocytes and 
osteoblasts differentiation. 
Alginate 1.75% with CaCl
2 
100mM (Figure 2 and 2a): At 37°C 
temperature showed MSCs growth increased after day 1 to day 7. After 
day 7, growth declined significantly and increased again after day 14. 
After the 21st day, the MSCs growth declined again. From Graph shows 
that the growth of MSCs in the microcapsule of alginate 1.75% with 
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Table 2: Stability of MSCs (Alginate 2% with CaCl
2 
100 mM) using Oil Red O, Alizarin Red and Alcian Blue staining. 
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CaCl
2 
100mM is unstable and irregular. At 25°C temperature showed 
MSCs growth increased after day 1 to day 7. After day 7, growth 
Alginate 1.25% with CaCl
2 
100mM 
MTT (3- (4,5-Dimethylthiazol-2-yl) -2,5-Diphenyltetrazolium 
declined significantly and increased again after day 21. After the 21st 
day, the MSCs growth increased again. From Graph shows that the 
Bromide) Assay (Figure 4): At alginat 1.25% with CaCl
2 
100mM, at 
growth of MSCs in the microcapsule of alginate 1.75% with CaCl
2 
100mM is unstable and irregular. 
Live Dead Assay (LDA) (Table 3) 
Stability assay: Stability of MSCs (Alginate 1,75% with CaCl
2 
100 
37°C, MSCs growth increased from day-0 to day-28. This shows that 
alginate 1.25% with CaCl
2 
100mM is good for MSCs growth (Figure 4a). 
At alginat 1.25% with CaCl
2 
100mM, at 25°C, MSCs growth increased 
from day-0 to day-28. This shows that alginat 1.25% with CaCl
2
100mM 
is good for MSCs growth. 
mM) using Oil Red O, Alizarin Red and Alcian blue staining (Table 4). Live Dead Assay (LDA): Viability of MSCs after alginate 
Alginate 1.5% with CaCl
2
 100mM (Figure 3 and 3a) 
encapsulated MSCs for day-0, day-1, day-7, day-14, day-21, and day-28 
using Live-dead cell assay (Alginate 1.25% with CaCl
2 
100mM) (Table 7). 
At  37°C temperature, MSCs growth increased from 0 to equal    
to day 14. After day 14, the growth of MSCs decreases and increases 
again after the 21st day until the 28th day. At 25°C temperature, MSCs 
growth increased from day 1 to day 28. While MSCs growth at 25°C 
temperature can grow well same at conditions at 37°C temperature is 
the optimum temperature for stem cells to grow. This Formula seems 
that suitable for MSCs-encapsulated grow. 
Livedeadassay(LDA): Viabilityof MSCsafteralginateencapsulated 
MSCs for day-0, day-1, day-7, day-14, day-21, and day-28 using Live- 
dead cell assay (Alginate 1.5% with CaCl
2 
100 mM) (Table 5). 
Stability assay: Stability of MSCs (Alginat 1.5% with CaCl
2 
100mM) 
using Oil Red O, Alizarin Red and Alcian blue staining (Table 6). From 
the stability analysis showed that there was no differentiation on MSC 
encapsulated for 28 days and still seen fibroblasts. 
Stability assay: Stability of MSCs (Alginate 1.25% with CaCl
2 
100mM) 
using Oil Red O, Alizarin Red and Alcian blue staining (Table 8). 
Alginate 1% with CaCl
2 
100 mM 
MTT (3- (4,5-Dimethylthiazol-2-yl) -2,5-Diphenyltetrazolium 
Bromide) Assay (Figure 5): At 37°C temperature MSCs growth has 
increased from day 0 to day 1. Furthermore, MSC growth decreased 
on day 7 and increased again until 21st day. On day 28, the growth of 
MSC shows a drastic decline. (Figure 5a) At alginat 1% with CaCl
2 
100 mM, at 25°C, MSCs growth increased from day 0 to day 28. 
This shows that alginat 1% with CaCl
2 
100 mM is good for MSCs 
growth. This can be due to the MSCs encapsulated can adapt and 
grow within the alginate microcapsule. In addition, the media may 
also to get into the microcapsule alginate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Absorbance value based on MTT assay of Alginate 1.75% with CaCl
2 
100 mM at 37 C 
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Figure 2a: Absorbance value based on MTT assay of Alginate 1.75% with CaCl
2 
100 mM at 25 C. 
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Table 3: Viability of MSCs after alginate encapsulated MSCs for day-0, day-1, day-7, day-14, day-21, and day-28 using Live-dead cell assay (Alginate 1.75% with CaCl
2 
100 mM). 
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Table 4: Stability of MSCs (Alginate 1.75% with CaCl
2 
100mM) using Oil Red O, Alizarin Red and Alcian blue staining. 
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Table 5: Viability of MSCs after alginate encapsulated MSCs for day-0, day-1, day-7, day-14, day-21, and day-28 using Live-dead cell assay (Alginate 1.5% with CaCl
2 
100 mM). 
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Figure 3: Absorbance value based on MTT assay of Alginate 1.5% with CaCl
2 
100 mM at 37°C 
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Figure 3a: Absorbance value based on MTT assay of Alginate 1.5% with CaCl
2 
100 mM at 25oC 
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Table 6: Stability of MSCs (Alginat 1.5% with CaCl
2 
100 mM) using Oil Red O, Alizarin Red and Alcian blue staining. 
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Figure 7: Viability of MSCs after alginate encapsulated MSCs for day-0, day-1, day-7, day-14, day-21, and day-28 using Live-dead cell assay (Alginate 1.25% with CaCl
2 
100 mM). 
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Figure 4: Absorbance value based on MTT assay of Alginate 1,25% with 
CaCl 100 mM at 37oC. 
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Figure 4a: Absorbance value based on MTT assay of Alginate 1.25% with 
CaCl 100 mM at 25oC. 
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Table 8: Stability of MSCs (Alginate 1.25% with CaCl
2 
100 mM) using Oil Red O, Alizarin Red and Alcian blue staining. 
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Live dead assay (LDA): Viability of MSCs after alginate 
encapsulated MSCs for day 0, day 1, day 7, day 14, day 21, and day 28 
using Live-dead cell assay (Alginate 1% with CaCl
2 
100 mM) (Table 9). 
Stability assay: After a 28-day encapsulation in alginate 
microcapsules there was no differentiation of MSCs in 
microencapsulation (Table 10). 
Conclusion 
The viability of mesenchymal stem cells in alginate microcapsules 
can last up to 28 days and there is no differentiation into adipose, 
chondrocytes and osteoblasts. It can suggest that MSCs encapsulated 
can use for transport MSCs from one laboratory to other laboratory for 
more than 24 hours. And also because of condition in other laboratory/ 
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Table 9: Viability of MSCs after alginate encapsulated MSCs for day-0, day-1, day-7, day-14, day-21, and day-28 using Live-dead cell assay (Alginate 1% with CaCl
2 
100 
mM). 
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Figure 5: Absorbance value based on MTT assay of Alginate 1% with CaCl
2 
100 mM at 37oC. 
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Figure 5a: Absorbance value based on MTT assay of Alginate 1% with CaCl
2 
100 mM at 25oC. 
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clinic which will use MSCs not always have liquid nitrogen storage. 
This result also shows that alginat with low concentration and CaCl
2 
100mM is good for MSCs growth (as in MTT result shown). This can be 
due to the MSCs encapsulated can adapt and grow within the alginate 
microcapsule with low concentration. In addition, the media may also 
easier to get into the microcapsule alginate. However these results need 
further investigations. 
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